Salvia miltiorrhiza ligustrazine prevention in elderly hip treatment in perioperative period of patients with cardio cerebral apoplexy fracture
10.3969/j.issn.1005-1678.2017.02.100
- VernacularTitle:丹参川穹嗪预防高龄髋部骨折患者围手术期心脑卒中的治疗进展
- Author:
Guobiao PAN
;
Wei WANG
;
Min WANG
- Keywords:
Salvia miltiorrhiza ligustrazine;
elderly patients;
hip fracture;
stroke
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(2):320-322
- CountryChina
- Language:Chinese
-
Abstract:
With the accelerating process of aging society, people's life style is changing accordingly, elderly patients due to physical decline in daily activities, often prone to hip fracture, its basic reason is osteoporosis, which belongs to brittle fracture, evaluation of preoperative examination and the systemic function is very important.Perioperative treatment is the key to the success of surgery treatment , a considerable part of the success of surgery depends on the factors of internal diseases.The incidence of cardio cerebral stroke in hip fracture surgery is also increasing , especially in elderly patients, often and there are a variety of medical diseases, the majority of organ function reserve is low, tolerance to anesthesia, surgery and other stress ability is poor, Patients in the perioperative period of traumatic stress, easily lead to stroke secondary cardiovascular disease, in clinical treatment, we should strengthen the prevention measures of perioperative stroke in elderly patients with hip fracture , Salvia miltiorrhiza ligustrazine injection can effectively prevent the occurrence of myocardial ischemia, myocardial infarction, or cerebral infarction by reducing platelet aggregation function and blood viscous degree, expanding coronary artery, cerebrovascular, improving the flow rate of red blood cells and microcirculation.In this paper mainly for Salvia miltiorrhiza ligustrazine in recent years in elderly hip fracture patients perioperative cardio cerebral apoplexy therapy application review to provide some reference value for clinical research .
